Literature DB >> 12427638

Discrepant MR spectroscopic and perfusion imaging results in a case of malignant transformation of cerebral glioma.

Wen-Chau Wu1, Cheng-Yu Chen, Hsiao-Wen Chung, Chun-Jung Juan, Chun-Jen Hsueh, Hong-Wei Gao.   

Abstract

We present serial MR perfusion and spectroscopic findings of a pathologically proved low grade glioma, which evolved into glioblastoma multiforme in 2 years in a 24-year-old man. The initial MR imaging studies, including enhanced conventional T1-weighted and perfusion imaging, were characteristic of a benign glioma with the only exception being that multi-voxel proton MR spectroscopy showed malignant features with a high choline:phosphocreatine ratio. Postoperative follow-up MR imaging revealed findings consistent with malignant glioma, with increased angiogenesis on perfusion images and heterogeneous enhancement on contrast-enhanced T1-weighted images that were further confirmed by second surgery. We suggest conducting close MR imaging follow-up of patients with glioma who have discrepant MR spectroscopic and perfusion results after treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427638      PMCID: PMC8185818     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

1.  Prevalence of glioblastoma multiforme in subjects with prior therapeutic radiation.

Authors:  L C Hodges; J L Smith; A Garrett; S Tate
Journal:  J Neurosci Nurs       Date:  1992-04       Impact factor: 1.230

2.  MR diffusion imaging of human intracranial tumours.

Authors:  K Krabbe; P Gideon; P Wagn; U Hansen; C Thomsen; F Madsen
Journal:  Neuroradiology       Date:  1997-07       Impact factor: 2.804

3.  Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.

Authors:  L L Wald; S J Nelson; M R Day; S E Noworolski; R G Henry; S L Huhn; S Chang; M D Prados; P K Sneed; D A Larson; W M Wara; M McDermott; W P Dillon; P H Gutin; D B Vigneron
Journal:  J Neurosurg       Date:  1997-10       Impact factor: 5.115

4.  Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.

Authors:  G Tedeschi; N Lundbom; R Raman; S Bonavita; J H Duyn; J R Alger; G Di Chiro
Journal:  J Neurosurg       Date:  1997-10       Impact factor: 5.115

5.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

Authors:  C Dowling; A W Bollen; S M Noworolski; M W McDermott; N M Barbaro; M R Day; R G Henry; S M Chang; W P Dillon; S J Nelson; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

6.  Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. Case report.

Authors:  Y Hayashi; M Iwato; M Hasegawa; O Tachibana; A von Deimling; J Yamashita
Journal:  J Neurosurg       Date:  2001-07       Impact factor: 5.115

7.  Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors.

Authors:  M Just; M Thelen
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

8.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

9.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.

Authors:  W G Negendank; R Sauter; T R Brown; J L Evelhoch; A Falini; E D Gotsis; A Heerschap; K Kamada; B C Lee; M M Mengeot; E Moser; K A Padavic-Shaller; J A Sanders; T A Spraggins; A E Stillman; B Terwey; T J Vogl; K Wicklow; R A Zimmerman
Journal:  J Neurosurg       Date:  1996-03       Impact factor: 5.115

10.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

Authors:  H J Aronen; I E Gazit; D N Louis; B R Buchbinder; F S Pardo; R M Weisskoff; G R Harsh; G R Cosgrove; E F Halpern; F H Hochberg
Journal:  Radiology       Date:  1994-04       Impact factor: 11.105

View more
  3 in total

1.  Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.

Authors:  G Çoban; S Mohan; F Kural; S Wang; D M O'Rourke; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-02       Impact factor: 3.825

2.  Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.

Authors:  J L Boxerman; K M Schmainda; R M Weisskoff
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

3.  Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.

Authors:  Kai Zhang; Chuanfu Li; Ying Liu; Li Li; Xiangxing Ma; Xiangshui Meng; Dechao Feng
Journal:  Neuroradiology       Date:  2007-09-01       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.